69 Based on an early analysis of 110 pediatric patients, the reduction in NT-proBNP over 12 weeks was 44% and 33% in the sacubitril-valsartan and enalapril groups, respectively, but it did not reach statistical significance.
← all excerpts
Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions.
1
—
—